2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 61.877 | 42.132 | 78.678 | 90.477 | 142.418 | 172.781 | 182.267 | 241.073 | 250.745 | 273.005 |
Total Income - EUR | 62.033 | 44.296 | 79.055 | 90.718 | 142.420 | 173.283 | 184.805 | 241.871 | 254.030 | 274.650 |
Total Expenses - EUR | 53.994 | 50.531 | 60.466 | 66.394 | 77.423 | 99.678 | 105.645 | 132.012 | 163.089 | 163.825 |
Gross Profit/Loss - EUR | 8.038 | -6.236 | 18.590 | 24.324 | 64.997 | 73.605 | 79.160 | 109.859 | 90.941 | 110.825 |
Net Profit/Loss - EUR | 6.178 | -7.508 | 17.803 | 22.671 | 63.573 | 71.957 | 77.553 | 107.858 | 88.670 | 108.622 |
Employees | 4 | 6 | 5 | 5 | 5 | 7 | 7 | 7 | 8 | 7 |
Check the financial reports for the company - Deraclin Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 19.892 | 50.441 | 40.534 | 35.796 | 54.345 | 59.991 | 165.832 | 214.422 | 214.148 | 199.981 |
Current Assets | 42.392 | 17.562 | 13.801 | 20.349 | 55.526 | 48.813 | 43.540 | 73.357 | 14.854 | 74.879 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.087 | 1.827 | 1.699 |
Receivables | 39.290 | 1.589 | 4.063 | 8.613 | 14.930 | 24.480 | 17.915 | 19.447 | 8.042 | 32.960 |
Cash | 3.102 | 15.974 | 9.738 | 11.736 | 40.596 | 24.333 | 25.625 | 52.823 | 4.984 | 40.219 |
Shareholders Funds | 53.112 | 43.370 | 10.425 | 32.920 | 63.624 | 89.987 | 108.154 | 174.240 | 143.177 | 251.364 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 44 | 43 | 42 | 43 | 42 |
Debts | 9.172 | 24.633 | 43.909 | 23.225 | 46.247 | 18.817 | 101.218 | 111.265 | 84.457 | 26.747 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.274 | 1.369 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8129 - 8129" | |||||||||
CAEN Financial Year |
8129
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Deraclin Srl